Research Study of Ischemia Using the CardiAQ Magnetocardiography Device in Adults Undergoing Heart Procedures

What this Trial Is About

Researchers are evaluating the usefulness of the CardiAQ MCG, a bedside magnetocardiography device, to study heart conditions related to acute coronary syndrome ACS and myocardial ischemia. This observational pilot study involves adult patients undergoing diagnostic angiography or revascularization procedures to assess their risk levels for ACS. The study aims to better understand how well the MCG device measures cardiac magnetic fields compared to standard angiography procedures. Participants use the Sponsor MCG device, which measures the hearts magnetic activity without shielding, around the time of their planned angiography or revascularization. The study classifies patients into low, medium, and high risk for ACS and collects data within 24 hours of their procedures. An additional safety follow-up on the MCG device use is conducted over 30 days. During the study, participants provide written consent and undergo the MCG measurement before their clinical heart procedure. Researchers compare MCG readings with angiography results taken within a day. Participants are monitored for device safety up to a month after use. The total study participation includes initial assessments around the procedure and follow-up safety monitoring.

A Prospective Research Investigation of Ischemia Using MCG